vs
FOX FACTORY HOLDING CORP（FOXF）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
FOX FACTORY HOLDING CORP的季度营收约是Orthofix Medical Inc.的1.7倍（$376.4M vs $219.9M），FOX FACTORY HOLDING CORP净利率更高（-0.2% vs -1.0%，领先0.8%），FOX FACTORY HOLDING CORP同比增速更快（4.8% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-2.5M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 6.4%）
福克斯工厂控股公司是一家美国企业，旗下最知名的产品为Fox Racing Shox品牌的越野赛车减震悬挂部件，该品牌在越野改装和赛车领域拥有较高知名度，深受越野运动爱好者与专业赛车队伍的认可。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
FOXF vs OFIX — 直观对比
营收规模更大
FOXF
是对方的1.7倍
$219.9M
营收增速更快
FOXF
高出2.8%
2.0%
净利率更高
FOXF
高出0.8%
-1.0%
自由现金流更多
OFIX
多$19.3M
$-2.5M
两年增速更快
OFIX
近两年复合增速
6.4%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $376.4M | $219.9M |
| 净利润 | $-634.0K | $-2.2M |
| 毛利率 | 30.4% | 71.1% |
| 营业利润率 | 4.0% | 0.2% |
| 净利率 | -0.2% | -1.0% |
| 营收同比 | 4.8% | 2.0% |
| 净利润同比 | -113.3% | 92.4% |
| 每股收益（稀释后） | $-0.02 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FOXFOFIX
| Q4 25 | $376.4M | $219.9M | ||
| Q3 25 | $374.9M | $205.6M | ||
| Q2 25 | $355.0M | $203.1M | ||
| Q1 25 | $352.8M | $193.6M | ||
| Q4 24 | — | $215.7M | ||
| Q3 24 | $359.1M | $196.6M | ||
| Q2 24 | $348.5M | $198.6M | ||
| Q1 24 | $333.5M | $188.6M |
净利润FOXFOFIX
| Q4 25 | $-634.0K | $-2.2M | ||
| Q3 25 | $2.7M | $-22.8M | ||
| Q2 25 | $-259.7M | $-14.1M | ||
| Q1 25 | $-141.0K | $-53.1M | ||
| Q4 24 | — | $-29.1M | ||
| Q3 24 | $4.8M | $-27.4M | ||
| Q2 24 | $5.4M | $-33.4M | ||
| Q1 24 | $-3.5M | $-36.0M |
毛利率FOXFOFIX
| Q4 25 | 30.4% | 71.1% | ||
| Q3 25 | 31.2% | 72.2% | ||
| Q2 25 | 30.9% | 68.7% | ||
| Q1 25 | 28.9% | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | 29.9% | 68.7% | ||
| Q2 24 | 31.8% | 67.8% | ||
| Q1 24 | 30.9% | 67.5% |
营业利润率FOXFOFIX
| Q4 25 | 4.0% | 0.2% | ||
| Q3 25 | 4.9% | -8.3% | ||
| Q2 25 | -70.6% | -7.9% | ||
| Q1 25 | 3.2% | -25.2% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | 5.2% | -9.6% | ||
| Q2 24 | 5.3% | -12.5% | ||
| Q1 24 | 2.7% | -15.6% |
净利率FOXFOFIX
| Q4 25 | -0.2% | -1.0% | ||
| Q3 25 | 0.7% | -11.1% | ||
| Q2 25 | -73.1% | -6.9% | ||
| Q1 25 | -0.0% | -27.4% | ||
| Q4 24 | — | -13.5% | ||
| Q3 24 | 1.3% | -13.9% | ||
| Q2 24 | 1.6% | -16.8% | ||
| Q1 24 | -1.0% | -19.1% |
每股收益（稀释后）FOXFOFIX
| Q4 25 | $-0.02 | $-0.05 | ||
| Q3 25 | $0.07 | $-0.57 | ||
| Q2 25 | $-6.23 | $-0.36 | ||
| Q1 25 | $0.00 | $-1.35 | ||
| Q4 24 | — | $-0.76 | ||
| Q3 24 | $0.11 | $-0.71 | ||
| Q2 24 | $0.13 | $-0.88 | ||
| Q1 24 | $-0.08 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $82.0M |
| 总债务越低越好 | $536.7M | — |
| 股东权益账面价值 | $956.0M | $450.0M |
| 总资产 | $2.0B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.56× | — |
8季度趋势，按日历期对齐
现金及短期投资FOXFOFIX
| Q4 25 | — | $82.0M | ||
| Q3 25 | — | $62.9M | ||
| Q2 25 | — | $65.6M | ||
| Q1 25 | $71.7M | $58.0M | ||
| Q4 24 | — | $83.2M | ||
| Q3 24 | — | $30.1M | ||
| Q2 24 | — | $26.4M | ||
| Q1 24 | — | $27.0M |
总债务FOXFOFIX
| Q4 25 | $536.7M | — | ||
| Q3 25 | $541.8M | $157.2M | ||
| Q2 25 | $546.9M | $157.0M | ||
| Q1 25 | $552.1M | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | $558.4M | $118.5M | ||
| Q2 24 | $564.1M | $118.0M | ||
| Q1 24 | $370.4M | $118.2M |
股东权益FOXFOFIX
| Q4 25 | $956.0M | $450.0M | ||
| Q3 25 | $958.7M | $442.5M | ||
| Q2 25 | $939.9M | $458.3M | ||
| Q1 25 | $1.2B | $458.3M | ||
| Q4 24 | — | $503.1M | ||
| Q3 24 | $1.2B | $525.9M | ||
| Q2 24 | $1.2B | $546.0M | ||
| Q1 24 | $1.2B | $570.3M |
总资产FOXFOFIX
| Q4 25 | $2.0B | $850.6M | ||
| Q3 25 | $2.0B | $832.6M | ||
| Q2 25 | $1.9B | $837.2M | ||
| Q1 25 | $2.2B | $823.1M | ||
| Q4 24 | — | $893.3M | ||
| Q3 24 | $2.3B | $867.9M | ||
| Q2 24 | $2.3B | $882.0M | ||
| Q1 24 | $2.2B | $906.0M |
负债/权益比FOXFOFIX
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.57× | 0.36× | ||
| Q2 25 | 0.58× | 0.34× | ||
| Q1 25 | 0.46× | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | 0.47× | 0.23× | ||
| Q2 24 | 0.47× | 0.22× | ||
| Q1 24 | 0.31× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.3M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-2.5M | $16.8M |
| 自由现金流率自由现金流/营收 | -0.7% | 7.6% |
| 资本支出强度资本支出/营收 | 2.1% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $85.4M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流FOXFOFIX
| Q4 25 | $5.3M | $27.7M | ||
| Q3 25 | $36.8M | $12.4M | ||
| Q2 25 | $680.0K | $11.6M | ||
| Q1 25 | $81.7M | $-18.4M | ||
| Q4 24 | — | $23.7M | ||
| Q3 24 | $14.1M | $11.7M | ||
| Q2 24 | $26.7M | $9.0M | ||
| Q1 24 | $9.4M | $-18.6M |
自由现金流FOXFOFIX
| Q4 25 | $-2.5M | $16.8M | ||
| Q3 25 | $24.6M | $2.5M | ||
| Q2 25 | $-6.5M | $4.5M | ||
| Q1 25 | $69.8M | $-25.1M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | $3.2M | $6.3M | ||
| Q2 24 | $15.4M | $-360.0K | ||
| Q1 24 | $-555.0K | $-29.1M |
自由现金流率FOXFOFIX
| Q4 25 | -0.7% | 7.6% | ||
| Q3 25 | 6.6% | 1.2% | ||
| Q2 25 | -1.8% | 2.2% | ||
| Q1 25 | 19.8% | -13.0% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | 0.9% | 3.2% | ||
| Q2 24 | 4.4% | -0.2% | ||
| Q1 24 | -0.2% | -15.4% |
资本支出强度FOXFOFIX
| Q4 25 | 2.1% | 4.9% | ||
| Q3 25 | 3.3% | 4.8% | ||
| Q2 25 | 2.0% | 3.5% | ||
| Q1 25 | 3.4% | 3.5% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | 3.0% | 2.7% | ||
| Q2 24 | 3.2% | 4.7% | ||
| Q1 24 | 3.0% | 5.6% |
现金转化率FOXFOFIX
| Q4 25 | — | — | ||
| Q3 25 | 13.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.94× | — | ||
| Q2 24 | 4.94× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FOXF
| Specialty Sports Group | $132.7M | 35% |
| Powered Vehicles Group | $125.9M | 33% |
| Aftermarket Applications Group | $117.8M | 31% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
